Peeress wants oral contraceptives to have P-medicine status
Questions are to be asked in the House of Lords about making oral contraception available without prescription from community pharmacies.
Baroness Finlay of Llandaff told The Journal this week: “We have
a high teenage pregnancy rate and a high abortion rate linked to unwanted
teenage pregnancies. Whatever we’re doing at the moment in terms
of contraception for youngsters isn’t working. I want to make advice
and contraception much more available.”
Baroness Finlay said that she wanted pharmacies to be able to sell oral
contraceptives over the counter.
She added that pharmacists would also be able to steer young women towards
family planning clinics if they thought that an intra-uterine device
was more appropriate.
The peeress was in no doubt that pharmacists were just as capable of
assessing a young woman’s thrombosis risk as GPs or family planning
clinic staff, because this was done by asking them about their family
history.
As well as asking questions in the House of Lords, Baroness Finlay intends
to discuss the matter with the relevant health minister and hopes that
it will be referred to the Medicines and Healthcare products Regulatory
Agency for consideration.
David Pruce, director of practice and quality improvement
at the Royal Pharmaceutical Society, said: “The Society, in principle,
supports the proposal to reclassify oral contraceptives from prescription-only
to pharmacy- medicine status.
“Pharmacists are experts in medicines and
have a track record of supplying medicines such as emergency hormonal
oral contraception over the counter and via patient group directions.
As such, they already have clinical skills and expertise that will help
them provide information and advice to women to ensure the appropriate
use of oral contraception.
“Reclassification of oral contraception would
widen and improve patient choice, access and convenience. Regarding the
necessary health checks, such as blood pressure testing and healthy lifestyle
checks, these are already a part of the pharmacist’s extended role.”
A conference to discuss possible
reclassification of oral contraceptives was held by the MHRA this year
(PJ, 10 February 2007, p153). |